Clinical Trial Update: Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses the potential pleiotropic effects of azilsartan medoxomil on insulin resistance in patients with hypertension, obesity, or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)

Snippet

Sponsor: Hospital General de México Dr. Eduardo Liceaga | Conditions: Hypertension, Obesity | Phase 2, Phase 3 | Status: UNKNOWN